J.L. Montero

2.7k total citations
56 papers, 1.3k citations indexed

About

J.L. Montero is a scholar working on Hepatology, Molecular Biology and Surgery. According to data from OpenAlex, J.L. Montero has authored 56 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hepatology, 15 papers in Molecular Biology and 13 papers in Surgery. Recurrent topics in J.L. Montero's work include Liver Disease Diagnosis and Treatment (12 papers), Liver Disease and Transplantation (11 papers) and Hepatocellular Carcinoma Treatment and Prognosis (9 papers). J.L. Montero is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Liver Disease and Transplantation (11 papers) and Hepatocellular Carcinoma Treatment and Prognosis (9 papers). J.L. Montero collaborates with scholars based in Spain, United States and Bulgaria. J.L. Montero's co-authors include Antonio Armario, Juan Balasch, Manuel de la Mata, Jordi Muntané, T. Jolín, Manuel Romero‐Gómez, Manuela Aguilar‐Guisado, J.A. Girón González, Francisco J. Caballero and Raúl J. Andrade and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

J.L. Montero

56 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.L. Montero Spain 20 470 424 193 184 174 56 1.3k
Giorgio Annoni Italy 21 347 0.7× 389 0.9× 411 2.1× 141 0.8× 503 2.9× 43 1.8k
Krzysztof Celiński Poland 22 260 0.6× 510 1.2× 183 0.9× 299 1.6× 266 1.5× 90 1.5k
Maria Słomka Poland 21 204 0.4× 488 1.2× 142 0.7× 295 1.6× 269 1.5× 87 1.4k
Yoshio Aizawa Japan 20 547 1.2× 581 1.4× 86 0.4× 106 0.6× 277 1.6× 157 1.4k
Amparo Urios Spain 23 657 1.4× 609 1.4× 141 0.7× 267 1.5× 446 2.6× 67 1.6k
Shao‐Chun Lu Taiwan 25 104 0.2× 368 0.9× 177 0.9× 229 1.2× 554 3.2× 54 1.7k
C L Mendenhall United States 18 637 1.4× 1.1k 2.5× 203 1.1× 128 0.7× 141 0.8× 40 1.6k
H Orrego Canada 26 631 1.3× 1.1k 2.7× 196 1.0× 223 1.2× 297 1.7× 60 2.2k
Robert F. Stachlewitz United States 21 297 0.6× 261 0.6× 154 0.8× 344 1.9× 600 3.4× 30 1.9k

Countries citing papers authored by J.L. Montero

Since Specialization
Citations

This map shows the geographic impact of J.L. Montero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.L. Montero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.L. Montero more than expected).

Fields of papers citing papers by J.L. Montero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.L. Montero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.L. Montero. The network helps show where J.L. Montero may publish in the future.

Co-authorship network of co-authors of J.L. Montero

This figure shows the co-authorship network connecting the top 25 collaborators of J.L. Montero. A scholar is included among the top collaborators of J.L. Montero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.L. Montero. J.L. Montero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zamora, Javier, Pilar Barrera, J.L. Montero, et al.. (2025). Early release of circulating tumor cells after transarterial chemoembolization hinders therapeutic response in patients with hepatocellular carcinoma. Journal of Translational Medicine. 23(1). 139–139. 1 indexed citations
2.
Zamora, Javier, J.L. Montero, Marina Sánchez‐Frías, et al.. (2024). Donor Atheromatous Disease is a Risk Factor for Hepatic Artery Thrombosis After Liver Transplantation. Clinical Transplantation. 38(7). e15405–e15405. 1 indexed citations
3.
Bilbao, Itxarone, Miguel Ángel Gómez‐Bravo, Alejandra Otero, et al.. (2023). Effectiveness and safety of once‐daily tacrolimus formulations in de novo liver transplant recipients: The PRETHI study. Clinical Transplantation. 37(12). e15105–e15105. 2 indexed citations
4.
Amado, Víctor, Javier Zamora, Marina Sánchez‐Frías, et al.. (2021). Clearance of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection or Liver Transplantation. Cancers. 13(10). 2476–2476. 22 indexed citations
5.
Aparici, Mònica, Israel Ramos, J.L. Montero, et al.. (2019). Pharmacological Profile of AZD8871 (LAS191351), a Novel Inhaled Dual M3 Receptor Antagonist/β2-Adrenoceptor Agonist Molecule with Long-Lasting Effects and Favorable Safety Profile. Journal of Pharmacology and Experimental Therapeutics. 370(1). 127–136. 14 indexed citations
6.
Ferrín, Gustavo, Manuel Rodríguez‐Perálvarez, Marina Sánchez‐Frías, et al.. (2019). mTOR Expression in Liver Transplant Candidates with Hepatocellular Carcinoma: Impact on Histological Features and Tumour Recurrence. International Journal of Molecular Sciences. 20(2). 336–336. 13 indexed citations
7.
Rodríguez‐Perálvarez, Manuel, et al.. (2017). Incidental hepatocellular carcinoma after liver transplantation: Prevalence, histopathological features and prognostic impact. PLoS ONE. 12(4). e0175010–e0175010. 11 indexed citations
8.
Ciria, Rubén, Pedro López‐Cillero, Arsenio Gallardo, et al.. (2015). Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma: Modern surgical resection as a feasible alternative to transarterial chemoemolization. European Journal of Surgical Oncology. 41(9). 1153–1161. 65 indexed citations
9.
Aparici, Mònica, Amadeu Gavaldà, Israel Ramos, et al.. (2015). In vitro and in vivo preclinical profile of abediterol (LAS100977), an inhaled long-acting β2-adrenoceptor agonist, compared with indacaterol, olodaterol and vilanterol. European Journal of Pharmacology. 770. 61–69. 19 indexed citations
10.
Gavaldà, Amadeu, Israel Ramos, Elena Calama, et al.. (2014). The in vitro and in vivo profile of aclidinium bromide in comparison with glycopyrronium bromide. Pulmonary Pharmacology & Therapeutics. 28(2). 114–121. 40 indexed citations
11.
Gavaldà, Amadeu, Elena Calama, J.L. Montero, et al.. (2011). Synthesis and biological activity of pyrido[3′,2′:4,5]furo[3,2-d]pyrimidine derivatives as novel and potent phosphodiesterase type 4 inhibitors. European Journal of Medicinal Chemistry. 46(10). 4946–4956. 14 indexed citations
12.
García-García, José Ángel, Manuel Romero‐Gómez, J.A. Girón González, et al.. (2006). Incidence of and Factors Associated with Hepatocellular Carcinoma among Hepatitis C Virus and Human Immunodeficiency Virus Coinfected Patients with Decompensated Cirrhosis. AIDS Research and Human Retroviruses. 22(12). 1236–1241. 15 indexed citations
13.
Pineda, Juan A., Manuel Romero‐Gómez, J.A. Girón González, et al.. (2005). HIV coinfection shortens the survival of patients with hepatitis C virus‐related decompensated cirrhosis†. Hepatology. 41(4). 779–789. 212 indexed citations
14.
Padillo–Ruiz, Javier, et al.. (2003). Immunomodulatory activity of TNF-α during acute liver injury induced by d-galactosamine and its protection by PGE1 in rats. International Immunopharmacology. 3(2). 197–207. 21 indexed citations
15.
Siendones, Emilio, Anna Colell, Carmen García‐Ruiz, et al.. (2002). PGE 1 Protection against Apoptosis Induced by d -galactosamine is Not Related to the Modulation of Intracellular Free Radical Production in Primary Culture of Rat Hepatocytes. Free Radical Research. 36(3). 345–355. 66 indexed citations
16.
Argüelles-Grande, Carolina, Francisco León, José Ramon Matilla, Jessica A. Dominguez, & J.L. Montero. (2002). Steroidal Management and Serum Cytokine Profile of a Case of Alcoholic Hepatitis with Leukemoid Reaction. Scandinavian Journal of Gastroenterology. 37(9). 1111–1113. 5 indexed citations
17.
Montero, J.L., et al.. (1991). The Pharmacological Profile of Aceclofenac, a New Nonsteroidal Antiinflammatory and Analgesic Drug. Birkhäuser Basel eBooks. 32. 125–129. 21 indexed citations
18.
Armario, Antonio, J.L. Montero, & T. Jolín. (1987). Chronic Food Restriction and the Circadian Rhythms of Pituitary-Adrenal Hormones, Growth Hormone and Thyroid-Stimulating Hormone. Annals of Nutrition and Metabolism. 31(2). 81–87. 76 indexed citations
19.
Jj, Corrales Hernández, et al.. (1985). Androgen Receptor Content in Cytosol from Non-Tumoral Human Kidney and Its Relation to Steroid Hormone Environment. Urologia Internationalis. 40(6). 307–313. 5 indexed citations
20.
Jara, Paloma, Rosa Codoceo, Ángel Hernánz, et al.. (1983). Serum Bile Acid Levels in Children with Chronic Persistent Hepatitis and Chronic Aggressive Hepatitis. Digestion. 27(2). 81–86. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026